Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-16-010490
Filing Date
2016-05-20
Accepted
2016-05-20 08:45:35
Documents
46
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ctxr_10q.htm 10-Q 304896
2 CERTIFICATION ctxr_ex311.htm EX-31.1 8753
3 CERTIFICATION ctxr_ex321.htm EX-32.1 3466
  Complete submission text file 0001477932-16-010490.txt   2022449

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT ctxr-20160331.xml EX-101.INS 339345
5 XBRL TAXONOMY EXTENSION SCHEMA ctxr-20160331.xsd EX-101.SCH 34239
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ctxr-20160331_cal.xml EX-101.CAL 35259
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctxr-20160331_def.xml EX-101.DEF 78099
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctxr-20160331_lab.xml EX-101.LAB 173354
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctxr-20160331_pre.xml EX-101.PRE 144638
Mailing Address 63 GREAT ROAD MAYNARD MA 01754
Business Address 63 GREAT ROAD MAYNARD MA 01754 (978) 938-0338
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-55532 | Film No.: 161664823
SIC: 3714 Motor Vehicle Parts & Accessories